Nicholas lain James Paton

Paton Nicholas lain James

Appointment(s)
  • Professor, Department of Medicine
  • Senior Consultant, Division of Infectious Disease, University Medicine Cluster, National University Health System
Administrative Appointment(s)
  • Research Director, University Medicine Cluster, National University Health System
  • Director, SPRINT-TB Programme, National University Health System
  • Lead, Tuberculosis Summit Research Programme, National University Health System
Academic Qualifications
  • BA, University of Cambridge, United Kingdom
  • MBBChir, University of Cambridge, United Kingdom
  • MA, University of Cambridge, United Kingdom
  • MD, University of Cambridge, United Kingdom
  • MSc (Epidemiology), University of Cambridge, United Kingdom
Research Interest(s)
  • HIV
  • Tuberculosis
  • Clinical Trials
  • Treatment
Recent Publications
  • 1. Arribas JR, Girard PM, Paton N, Winston A, Marcelin AG, Elbirt D, Hill A, Hadacek MB. 2016 May. Efficacy of protease inhibitor monotherapy vs. triple therapy: meta-analysis of data from 2303 patients in 13 randomized trials. HIV Med. 17(5):358-67. doi: 10.1111/hiv.12348. 26709605.
  • 2. Kambugu A, Thompson J, Hakim J, Tumukunde D, van Oosterhout JJ, Mwebaze R, Hoppe A, Abach J, Kwobah C, Arenas-Pinto A, Walker SA, Paton NI; EARNEST Trial Team. 2016 Apr. Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial. J Acquir Immune Defic Syndr. 71(5):506-13. doi: 10.1097/QAI.0000000000000898. 26579985.
  • 3. Molton JS, Leek FA, Ng LH, Totman JJ, Paton NI. 2016 Mar. A Novel Approach to CT, MR, and PET Examination of Patients with Infections Requiring Stringent Airborne Precautions. Radiology. 278(3):881-7. doi: 10.1148/radiol.2015150289. 26402398.
  • 4. Paton NI, Stöhr W, Arenas-Pinto A, Fisher M, Williams I, Johnson M, Orkin C, Chen F, Lee V, Winston A, Gompels M, Fox J, Scott K, Dunn DT; Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) Trial Team. 2015 Oct. Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial. The lancet. Lancet HIV. 2(10):e417-26. doi: 10.1016/S2352-3018(15)00176-9. 26423649.
  • 5. Hoehn KB, Gall A, Bashford-Rogers R, Fidler SJ, Kaye S, Weber JN, McClure MO; SPARTAC Trial Investigators, Kellam P, Pybus OG. 2015 Sep. Dynamics of immunoglobulin sequence diversity in HIV-1 infected individuals. Philos Trans R Soc Lond B Biol Sci. 370(1676). doi: 10.1098/rstb.2014.0241. 26194755.